Position in DNA
as of Mar 31, 2026
· filed Apr 23, 2026
Position Value
$514,337
+$38,233 QoQ
Shares Held
83,905
+46.4% QoQ
Ownership
0.128%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2025
3 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in DNA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Inspire Investing, LLC holds $15,476,636 across 43 Biotechnology names. DNA ranks #15 (3.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RIGL |
Rigel Pharmaceuticals Inc
|
63,891 | $1,727,612 | |
| 2 | ROIV |
Roivant Sciences Ltd.
|
58,781 | $1,628,233 | |
| 3 | RPRX |
Royalty Pharma plc
|
26,653 | $1,278,544 | |
| 4 | JAZZ |
Jazz Pharmaceuticals plc
|
5,462 | $1,032,591 | |
| 5 | INCY |
Incyte Corp
|
8,968 | $844,068 | |
| 6 | PGEN |
Precigen, Inc.
|
136,122 | $526,792 | |
| 7 | BHVN |
Biohaven Ltd.
|
61,915 | $523,800 | |
| 8 | GERN |
Geron Corp
|
349,627 | $520,944 |
All Filings in DNA
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $514,337 | 83,905 | Shares | Sole | 2026-04-23 | |
| 2025-12-31 | $476,104 | 57,293 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $460,392 | 31,577 | Shares | Sole | 2025-10-15 | |
| No filing history on record for this holder in this stock. | ||||||